Granules India Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 8,83,843 shares,. Its Average Traded Price (ATP) is ₹803.81, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 10 @ ₹794.75.
Granules India has an upper circuit limit of ₹953.70 and a lower circuit limit of ₹635.80. The total value traded stands at ₹71.04 CR, and the delivery percentage for the day is 56.84%.
The stock is currently traded with a market lot size of 1. Granules India also offers a dividend yield of 0.22%.
Granules India Share Price Chart
Granules India Share Key Metrics
Volume
8.84 L
Market Cap
19693.66 CR
LTQ@LTP
10@794.75
ATP
803.81
Var Margin
16.15 %
Circuit Range
635.8-953.7
Delivery %
56.84 %
Value
71.04 CR
ASM/GSM
No
Market Lot
1
Granules India Resistance and Support
Pivot 811.1
Resistance
First Resistance
826.15
Second Resistance
835.3
Third Resistance
850.35
Support
First Support
801.95
Second Support
786.9
Third Support
777.75
Granules India Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Granules India Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-21 | Quarterly Results |
| 2026-04-29 | Audited Results & Final Dividend |
| 2026-01-23 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-28 | Audited Results & Final Dividend |
| 2025-01-24 | Quarterly Results |
| 2024-11-06 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-30 | 2026-07-30 | View More |
Granules India News
Granules India Ltd-$ - 532482 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Granules India promoter group acquired 2.49 crore warrants convertible into equity shares on a preferential basis. The warrants were allotted at Rs.585 each, increasing the promoter group's total diluted shareholding to 43.69%.
Oct 24 2026 11:43:37
Granules India Ltd-$ - 532482 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Granules India's promoter group acquired 2,49,82,906 equity shares, representing a 9.16% stake, through the conversion of preferential warrants. This increases the total promoter holding to 37.39%.
Oct 24 2026 11:42:07
Granules India Ltd-$ - 532482 - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Promoter Dr Krishna Prasad Chigurupati sold 1,72,00,000 equity shares of Granules India, accounting for a 6.94% stake. Post this transaction, his holding in the company stands reduced from 31.00% to 24.06%.
Oct 24 2026 11:39:23
Granules India Ltd-$ - 532482 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Second Quarter And Half-Year Ended On September 30, 2026
Granules board to meet on 02 November 2026 for financial results. The meeting will cover the quarter and half-year ended September 2026.
Oct 23 2026 15:25:21
Granules India Ltd-$ - 532482 - Transcript Of The Webinar
Granules India shared its future strategy during a recent webinar, highlighting four key growth engines: controlled substances, complex generics, oncologies, and peptide CDMO. The company plans to invest Rs.2,000 crore over the next 3-4 years and aims for a $50 million annual revenue run rate for its peptide CDMO business in three years.
Oct 06 2026 17:30:20
Granules India Ltd-$ - 532482 - Incorporation Of A Wholly Owned Foreign Subsidiary
Granules India has incorporated a wholly-owned foreign subsidiary named TRITON FARMACEUTICA DO BRASIL LTDA in Brazil. The new entity will manufacture, promote, sell, and distribute pharmaceuticals and related products in the region.
Oct 02 2026 20:34:59
Granules India Ltd-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Granules India will host an investor webinar on September 29, 2026, at 4:30 p.m. IST, organized by IIFL Capital. The session will cover the company's strategic transformation journey, focusing on new growth engines and evolving business mix for future growth and margin expansion.
Sep 26 2026 20:11:42
Granules India Management
| Name | Position |
|---|---|
| Krishna Prasad Chigurupati | Chairman & Managing Director |
| Uma Devi Chigurupati | Whole Time Director |
Granules India Similar Stocks
Krishna Institute of Medical Sciences Ltd
665.15
-3.40 (0.51%)
Acutaas Chemicals Ltd.
3137.70
-77.60 (2.41%)
Piramal Pharma Ltd.
191.07
-3.92 (2.01%)
Neuland Laboratories Ltd.
18865.00
-70.00 (0.37%)
Rubicon Research Ltd.
1424.40
-12.20 (0.85%)
Astrazeneca Pharma India Ltd.
5988.50
-112.50 (1.84%)
Cohance Lifesciences Ltd.
449.85
-4.00 (0.88%)
Pfizer Ltd.
3612.30
-76.60 (2.08%)
Caplin Point Laboratories Ltd.
2222.00
-27.10 (1.20%)
Shilpa Medicare Ltd.
864.30
3.50 (0.41%)
Granules India FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in GRANULES
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC